米国の創傷デブリードマン市場規模・シェア・動向分析レポート：製品タイプ別、方法別、創傷タイプ別、最終用途別、購入形態別、セグメント予測、2025～2033年

米国の創傷デブリードマン市場概要

米国の創傷デブリードマン市場規模は2024年に15億3,000万米ドル、2033年には22億6,000万米ドルに達すると予測され、2025～2033年にかけてCAGR 4.3％で成長します。糖尿病、肥満の蔓延、外傷や慢性創傷の増加が、高度創傷デブリードマンソリューションの需要を牽引し続けています。

CDCによると、約1億2,900万人の米国人が少なくとも1つの主要な慢性疾患を抱えて生活しており、人口の2％近くが慢性創傷を患っています。糖尿病性足潰瘍、褥瘡、静脈うっ滞性潰瘍などのこれらの創傷は、臨床上大きな課題をもたらし、治癒期間の延長、合併症リスクの増大、多大なヘルスケア資源の消費に関連しています。

規制と技術革新の面では、FDAのような米国連邦機関が積極的に情勢を再構築しています。FDAは特定の創傷ケア製品（抗菌剤を含むジェル、クリーム、軟膏、液体洗浄剤）をクラスⅡまたはⅢの機器に再分類することを提案しており、510（k）届出や市販前承認（PMA）を通してより厳格なモニタリングが必要となります。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の創傷デブリードマン市場の変動動向と展望

• 市場系統の展望
  • 親市場
  • 補助市場
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 米国の創傷デブリードマン市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析
  • 規制の枠組み

第4章 米国の創傷デブリードマン市場：製品別、推定・動向分析

• セグメントダッシュボード
• 米国の創傷デブリードマン市場：製品変動分析
• 米国の創傷デブリードマン市場規模と動向分析（製品別、2021～2033年）
• ゲル
• 軟膏とクリーム
• 外科用機器
• 医療用ガーゼ
• 超音波装置

第5章 米国の創傷デブリードマン市場：方法別、推定・動向分析

• セグメントダッシュボード
• 米国の創傷デブリードマン市場：方法変動分析
• 米国の創傷デブリードマン市場規模と動向分析（方法別、2021～2033年）
• 自己分解
• 酵素
• 外科手術
• 機械
• その他

第6章 米国の創傷デブリードマン市場：創傷タイプ別、推定・動向分析

• セグメントダッシュボード
• 米国の創傷デブリードマン市場：創傷タイプ変動分析
• 米国の創傷デブリードマン市場規模と動向分析（創傷タイプ別、2021～2033年）
• 褥瘡
• 糖尿病性足潰瘍
• 静脈性下肢潰瘍
• 火傷
• その他

第7章 米国の創傷デブリードマン市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 米国の創傷デブリードマン市場：最終用途変動分析
• 米国の創傷デブリードマン市場規模と動向分析（最終用途別、2021～2033年）
  • 病院
  • 在宅医療
  • その他

第8章 米国の創傷デブリードマン市場：購入形態別、推定・動向分析

• セグメントダッシュボード
• 米国の創傷デブリードマン市場：購入形態変動分析
• 米国の創傷デブリードマン市場規模と動向分析（購入形態別、2021～2033年）
  • 処方箋
  • 市販薬
  • その他

第9章 競合情勢

• 市場参入企業の分類
• 企業の市況分析/ヒープマップ分析
• 企業プロファイル
  • Zimmer Biomet
  • Smith+Nephew
  • Coloplast Group
  • Convatec Group PLC
  • CR Bard
  • Lohmann & Rauscher

List of Tables

• Table 1 List of Secondary Sources
• Table 2 U.S. Wound Debridement Market, by Product, 2021 - 2033 (USD Million)
• Table 3 U.S. Wound Debridement Market, by Method/Procedures, 2021 - 2033 (USD Million)
• Table 4 U.S. Wound Debridement Market, by Wound Type, 2021 - 2033 (USD Million)
• Table 5 U.S. Wound Debridement Market, by End Use, 2021 - 2033 (USD Million)
• Table 6 U.S. Wound Debridement Market, by Mode of Purchase, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market Segmentation
• Fig. 2 Market Research Process
• Fig. 3 Information Procurement
• Fig. 4 Primary Research Pattern
• Fig. 5 Market Research Approaches
• Fig. 6 Value Chain-Based Sizing & Forecasting
• Fig. 7 QFD Modelling for Market Share Assessment
• Fig. 8 Market Formulation & Validation
• Fig. 9 U.S. Wound Debridement Market Revenue, 2021 - 2033 (USD Million)
• Fig. 10 U.S. Wound Debridement Market Snapshot
• Fig. 11 U.S. Wound Debridement Market Driver Impact
• Fig. 12 U.S. Wound Debridement Market Restraint Impact
• Fig. 13 U.S. Wound Debridement Product Key Takeaways (USD Million)
• Fig. 14 U.S. Wound Debridement Market: Product Movement Analysis
• Fig. 15 Gels Market, 2021 - 2033 (USD Million)
• Fig. 16 Ointments & Creams Market, 2021 - 2033 (USD Million)
• Fig. 17 Surgical Devices Market, 2021 - 2033 (USD Million)
• Fig. 18 Medical Gauzes Market, 2021 - 2033 (USD Million)
• Fig. 19 Ultrasonic Devices Market, 2021 - 2033 (USD Million)
• Fig. 20 Others Market, 2021 - 2033 (USD Million)
• Fig. 21 U.S. Wound Debridement Method/Procedure Key Takeaways (USD Million)
• Fig. 22 U.S. Wound Debridement Market: Method/Procedure Movement Analysis
• Fig. 23 Autolytic Market, 2021 - 2033 (USD Million)
• Fig. 24 Enzymatic Market, 2021 - 2033 (USD Million)
• Fig. 25 Surgical Market, 2021 - 2033 (USD Million)
• Fig. 26 Mechanical Market, 2021 - 2033 (USD Million)
• Fig. 27 Others Market, 2021 - 2033 (USD Million)
• Fig. 28 U.S. Wound Debridement Market Wound Type Key Takeaways (USD Million)
• Fig. 29 U.S. Wound Debridement Market: Wound Type Movement Analysis
• Fig. 30 Pressure Ulcers Market, 2021 - 2033 (USD Million)
• Fig. 31 Diabetic Foot Ulcers Market, 2021 - 2033 (USD Million)
• Fig. 32 Venous Leg Ulcers Market, 2021 - 2033 (USD Million)
• Fig. 33 Burn Wound Market, 2021 - 2033 (USD Million)
• Fig. 34 Others Market, 2021 - 2033 (USD Million)
• Fig. 35 U.S. Wound Debridement Market By End Use Key Takeaways (USD Million)
• Fig. 36 U.S. Wound Debridement Market: By End Use Movement Analysis
• Fig. 37 Homecare Market, 2021 - 2033 (USD Million)
• Fig. 38 Hospitals Market, 2021 - 2033 (USD Million)
• Fig. 39 Others Market, 2021 - 2033 (USD Million)
• Fig. 40 U.S. Wound Debridement Market Mode of Purchase Key Takeaways (USD Million)
• Fig. 41 U.S. Wound Debridement Market: Mode of Purchase Movement Analysis
• Fig. 42 Prescription Market, 2021 - 2033 (USD Million)
• Fig. 43 Over The Counter Market, 2021 - 2033 (USD Million)
• Fig. 44 Others Market, 2021 - 2033 (USD Million)

U.S. Wound Debridement Market Summary

The U.S. wound debridement market size was valued at USD 1.53 billion in 2024 and is projected to reach USD 2.26 billion by 2033, growing at a CAGR of 4.3% from 2025 to 2033. The increasing prevalence of diabetes, obesity, and the growing number of traumatic injuries and chronic wounds continue to drive demand for advanced wound debridement solutions.

According to the CDC, approximately 129 million Americans live with at least one major chronic illness, and nearly 2% of the population suffers from chronic wounds, with incidence rising notably among older adults. These wounds, such as diabetic foot ulcers, pressure sores, and venous stasis ulcers, present significant clinical challenges and are associated with extended healing times, increased risk of complications, and substantial healthcare resource consumption.

On the regulatory and innovation front, U.S. federal agencies like the FDA are actively reshaping the landscape. The FDA has proposed reclassifying certain wound-care products-gels, creams, ointments, and liquid washes containing antimicrobials-into Class II or III devices, requiring more rigorous oversight through 510(k) notifications or premarket approvals (PMAs).

U.S. Wound Debridement Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. wound debridement market report based on product, method, wound type, mode of purchase, and end use:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Gels
• Ointments & Creams
• Surgical Devices
• Medical Gauzes
• Ultrasonic Devices
• Others
• Method/Procedure Outlook (Revenue, USD Million, 2021 - 2033)
• Autolytic
• Enzymatic
• Surgical
• Mechanical
• Others
• Wound Type Outlook (Revenue, USD Million, 2021 - 2033)
• Pressure Ulcers
• Diabetic Foot Ulcers
• Venous Leg Ulcers
• Burn Wound
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Homecare
• Others
• Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)
• Prescription
• Over The Counter
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Wound Debridement Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. U.S. Wound Debridement Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework

Chapter 4. U.S. Wound Debridement Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Wound Debridement Market: Product Movement Analysis
• 4.3. U.S. Wound Debridement Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Gels
  • 4.4.1. Gels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Ointments & Creams
  • 4.5.1. Ointments & Creams Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Surgical Devices
  • 4.6.1. Surgical Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Medical Gauzes
  • 4.7.1. Medical Gauzes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Ultrasonic Devices
  • 4.8.1. Ultrasonic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Wound Debridement Market: Method/Procedures Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Wound Debridement Market: Method/Procedures Movement Analysis
• 5.3. U.S. Wound Debridement Market Size & Trend Analysis, by Method/Procedures, 2021 to 2033 (USD Million)
• 5.4. Autolytic
  • 5.4.1. Autolytic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Enzymatic
  • 5.5.1. Enzymatic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Surgical
  • 5.6.1. Surgical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Mechanical
  • 5.7.1. Mechanical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Wound Debridement Market: Wound Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Wound Debridement Market: Wound Type Movement Analysis
• 6.3. U.S. Wound Debridement Market Size & Trend Analysis, by Wound Type, 2021 to 2033 (USD Million)
• 6.4. Pressure Ulcers
  • 6.4.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Diabetic Foot Ulcers
  • 6.5.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Venous Leg Ulcers
  • 6.6.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Burn Wound
  • 6.7.1. Burn Wound Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Others
  • 6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Wound Debridement Market: By End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. U.S. Wound Debridement Market: By End Use Movement Analysis
• 7.3. U.S. Wound Debridement Market Size & Trend Analysis, by End use, 2021 to 2033 (USD Million)
  • 7.3.1. Hospitals
    • 7.3.1.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. Homecare
    • 7.3.2.1. Homecare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Others
    • 7.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. U.S. Wound Debridement Market: By Mode of Purchase Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. U.S. Wound Debridement Market: By Mode of Purchase Movement Analysis
• 8.3. U.S. Wound Debridement Market Size & Trend Analysis, by Mode of Purchase, 2021 to 2033 (USD Million)
  • 8.3.1. Prescription
    • 8.3.1.1. Prescription Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. Over the Counter
    • 8.3.2.1. Over the Counter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Others
    • 8.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Company Market Position Analysis/ Heap Map Analysis
• 9.3. Company Profiles
  • 9.3.1. Zimmer Biomet
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Smith+Nephew
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Coloplast Group
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Convatec Group PLC
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. C. R. Bard
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Lohmann & Rauscher
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product Benchmarking
    • 9.3.6.4. Strategic Initiatives